Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GALNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB5C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100270804 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HOMER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLUL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GK6P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRIM23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESYT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1324 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCP11L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505555 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGIX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on